Moreover, novel inhibitors of Ret signaling targeting Raf, Src, and S6-Kinase (S6K) prevent lethality induced by Ret over-activation in a Drosophila multiple endocrine neoplasia (MEN2) model (Dar et al., 2012). This evidence concerns the gene SRC and multiple endocrine neoplasia.